Pharmaceutical compositions and process for making them

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 31/00 (2006.01) A61K 31/192 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2694378

Amorphous HMG CoA reductase inhibitors, especially amorphous atorvastatin, are described. Also described are pharmaceutical combinations comprising amorphous HMG CoA reductase inhibitors in combination with cholesterol absorption inhibitors or fibrates. A method of manufacturing the compositions using a hot melt extrusion process are also described.

L'invention concerne des inhibiteurs de HMG-CoA réductase sous forme amorphe, et notamment de l'atorvastatine amorphe. L'invention concerne également des combinaisons pharmaceutiques comprenant des inhibiteurs de HMG-CoA réductase sous forme amorphe en combinaison avec des inhibiteurs de l'absorption du cholestérol ou des fibrates. L'invention se rapporte en outre à un procédé de préparation de ces compositions au moyen d'une technique d'extrusion à chaud.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions and process for making them does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and process for making them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and process for making them will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1763979

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.